Company Performance: Revenue growth, earnings reports, and successful clinical trial outcomes for its antiviral therapies significantly impact investor confidence and the stock price.

Market Sentiment: Overall investor optimism or pessimism regarding the biotechnology sector and the broader market conditions influence trading volume and VIRX.US's stock valuation.

Regulatory Approvals: Receiving FDA or other regulatory body approvals for its products greatly increases market access and potential revenue streams, driving up the stock price.

Competition: The emergence of competing antiviral therapies or companies in the same market space can negatively affect VIRX.US's stock price due to concerns about market share.

Partnerships and Acquisitions: Strategic collaborations, licensing agreements, or potential acquisition offers can significantly boost investor sentiment and the stock price.

News and Media: Positive or negative news coverage regarding the company, its products, or the industry as a whole can influence investor behavior and stock price fluctuations.